Carasent ASA: Carasent ASA acquires Metodika AB
Press release
May 25, 2021
Carasent ASA acquires Metodika AB
Carasent ASA has acquired the Swedish company Metodika AB ("Metodika"), a
leading provider of
Enterprise Practice Management (EPM) solutions to independent hospitals and
clinics across 10 European
countries.
We are very pleased to have completed this transaction as Metodika, with its
complementary market
presence will expand Carasent's geographical footprint significantly by giving
access to new European
markets such as Denmark, Finland, UK, Germany and Italy, says Dennis Höjer, CEO
of Carasent.
Metodika EPM software streamlines information management and efficiently helps
its clients with handling
the day-to-day operations of clinics and hospitals. The product platform also
includes a tool for inpatient
care that is complementary to Carasent's current offering.
- We are impressed by the EPM solution that the Metodika team has developed and
look forward to work
with its robust organization of 22 highly competent employees. The tool for
treatment and surgery will
expand our product offering and enable us to service our clients in a new
sub-segment. In summary, this
transaction is well in-line with communicated strategic priorities of expanding
within geographical, segment
and product dimensions, he says.
Metodika has an attractive customer base of more than 50 clients across Europe.
The company also has
growing SaaS-business that can be further intensified under Carasent ownership.
Metodika's revenues and EBITDA were approximately SEK 28 million and SEK 2
million as per year-end
2020, with recurring revenues of approximately SEK 20 million. Metodika has
delivered consistent historical
organic growth, with 10% revenue and 14% recurring revenue CAGR from 2013-2020.
However, through
leveraging Carasent and Metodika's combined scale and product offering in
existing and new markets,
there are great opportunities to accelerate the growth going forward.
The purchase price will be SEK 114 million, corresponding to an enterprise value
of SEK 108 million less
Metodika's consolidated net cash position of SEK 6 million (the ("Purchase
Price").
The transaction purchase price will be settled as follows:
- ~80% of the Purchase Price in cash upon closing,
- ~20% of the Purchase Price as shares in Carasent valued at a price of NOK 39.1
per share,
corresponding to the 30-day VWAP at 20 May 2021 (the "Share Settlement").
Danske Bank acted as financial advisor to Carasent in connection with the
transaction.
Attached is an updated Company presentation.
